# Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project

## Barcelona, Spain AML & ALL Related Centers Archive

![Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project](https://www.PeterMossAmlAllResearch.com/media/images/banner.png)

<hr />

&nbsp;

# Barcelona, Spain AML & ALL Related Centers Archive

&nbsp;

# Hospital Clínic Barcelona, Barcelona, Spain

Hospital Clínic Barcelona iks a Leukemia research center Barcelona. Keep up to date with what is happening on the official Hospital Clínic de Barcelona blogThanks to Toni for sharing the link!

**WEBSITE:** [HospitalClinic.org](http://blog.hospitalclinic.org/en/tag/leucemia-en "HospitalClinic.org")

<hr />

# Josep Carreras Leukaemia Research Institute, Barcelona, Spain

In 2010 the Josep Carreras Foundation, together with the Generalitat de Catalunya (Government of Catalonia), launched an historic and unprecedented project: the first European research centre devoted exclusively to leukaemia and other malignant blood diseases, and one of the few that exist in the world.

**PHONE:** (+34) 93 557 2800  
**WEBSITE:** [CarrerasResearch.org](http://www.carrerasresearch.org/en "CarrerasResearch.org")

<hr />

# Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project, Sabadell, Spain

The Peter Moss Acute Myeloid / Lymphoblastic Leukemia AI Research Project is an open source project with the goals of leveraging Artificial Intelligence to help detect AML/ALL and discover potential candidates for drugs to help combat the diseases.

This project is in memory of Peter Edward Moss who lost his battle with Acute Myeloid Leukemia in August 2019. The project is run entirely by volunteers and is not a registered Non Profit.

**PHONE:** (+34) 60 33 58 245
**WEBSITE:** [PeterMossAmlAllResearch.com](http://www.PeterMossAmlAllResearch.comn "PeterMossAmlAllResearch.com")

<hr />

&nbsp;

# Community Driven

The project was initially created with the hope other developers and people in the medical industry may find the software and tutorials useful and may contribute back to the Github community helping improve the project. Feel free to submit pull requests with your suggested edits / bug fixes / additions to the related repositories on Github.

## Contributing

The Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research project encourages and welcomes code contributions, bug fixes and enhancements from the Github.

Please read the [CONTRIBUTING](https://github.com/AMLResearchProject/AML-ALL-Research-Archive/blob/master/CONTRIBUTING.md "CONTRIBUTING") document for a full guide to forking our repositories and submitting your pull requests. You will also find information about our code of conduct on this page.

### Acute Myeloid & Lymphoblastic Leukemia Classifiers Contributors

- [Adam Milton-Barker](https://www.petermossamlallresearch.com/team/adam-milton-barker/profile "Adam Milton-Barker") - Bigfinite IoT Network Engineer & Intel Software Innovator, Barcelona, Spain
- [Ho Leung Ng](https://www.petermossamlallresearch.com/team/ho-leung-ng/profile "Ho Leung Ng") - Associate Professor of Biochemistry & Molecular Biophysics at Kansas State University, USA

&nbsp;

# Versioning

We use SemVer for versioning. For the versions available, see [Releases](https://github.com/AMLResearchProject/AML-ALL-Research-Archive/releases "Releases").

# License

This project is licensed under the **MIT License** - see the [LICENSE](https://github.com/AMLResearchProject/AML-ALL-Research-Archive/blob/master/LICENSE "LICENSE") file for details.

# Bugs/Issues

We use the [repo issues](https://github.com/AMLResearchProject/AML-ALL-Research-Archive/issues "repo issues") to track bugs and general requests related to using this project.
